Global Nuclear Imaging Equipment
Market Report
2024
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Nuclear Imaging Equipment Market Report 2024.
"Global Nuclear Imaging Equipment market size 2023 was XX Million. Nuclear Imaging Equipment Industry compound annual growth rate (CAGR) will be XX% from 2024 till 2031."
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Market Size | 121212 |
Country Market Size | 121212 |
North Americ Market Size | 121212 |
Europe Market Size | 121212 |
Asia Pacific Market Size | 121212 |
South America Market Size | 121212 |
Middle East and Africa Market Size | 121212 |
Market Split by Type |
|
Market Split by Application |
|
Market Split by End users |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Nuclear Imaging Equipment industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Nuclear Imaging Equipment Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Nuclear imaging is a technique for creating pictures by detecting radiation from various body areas after the patient is given a radioactive tracer. The images are made digitally on a computer and forwarded to a nuclear imaging physician who uses them to diagnose patients.
Nuclear imaging can also be used to diagnose problems or monitor the effectiveness of treatment. Administer radiation accurately to a particular location, radioimmunotherapy, which combines radiation with immunotherapy, is one example of this.
The market for nuclear imaging equipment is expanding because of several factors, including rising growth in the geriatric population, rising cases of cancer and heart diseases, increasing technological advancement, and increased medical reimbursement for such procedures in developed regions, furthermore, government support, increasing rate of a strategic initiative by market players.
Driving factors:
Increasing prevalence of cancer and cardiovascular diseases:
According to WHO, approximately 10 million deaths, or around one in six deaths, will be caused by cancer in 2020, making it the top cause of death globally. 400000 kids are diagnosed with cancer in youngsters every year. The most prevalent malignancies differ between nations. In 23 nations, cervical cancer is the most prevalent kind. 685000 women worldwide died in 2020 because of breast cancer, which affected 2.3 million women. Breast cancer is the most common cancer in the world, with 7.8 million women alive as of the end of 2020 who had received a diagnosis during the previous five years. As cancer cases increase, demand for diagnosis such as nuclear imaging equipment also increases.
Similarly, according to WHO, According to research, 17.9 million deaths worldwide in 2019 were caused by CVDs or 32% of the total number of deaths. Heart attack and stroke deaths accounted for 85% of these deaths. The majority of CVD deaths occur in low- and middle-income nations. In 2019, noncommunicable illnesses caused 17 million premature deaths (before age 70), and 38% of those deaths were attributable to CVDs. Which increases the demand for nuclear imaging equipment and boosts the market.
Rising geriatric population:
All countries face significant challenges to ensure that their health and social systems are ready to make the most of this demographic shift. The pace of population aging is much faster than in the past.
According to WHO, estimates that by 2030, 1 in 6 individuals worldwide would be 60 years of age or older. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. Aging increases the risk of chronic diseases such as dementia, heart disease, type 2 diabetes, arthritis, and cancer. Due to the growing geriatric population, the number of chronic and cardiovascular diseases increases which rises the demand for nuclear imaging equipment.
Restraining factors:
High cost of imaging procedure and strict regulations:
Patients' costs for nuclear imaging systems rise as a result of the considerable investment required for installation, which also raises their out-of-pocket expenses. Customers have been forced to migrate to used systems as a result, which hurts their financial results. The adoption of new systems is impacted by this.
The Nuclear Regulatory Commission's (NRC) stringent guidelines for medical usage place restrictions on the market for nuclear imaging systems and equipment. For instance, the NRC requires license holders of nuclear imaging equipment to utilize and store radioactive materials to protect employees and people by preventing unintentional exposure, which results in a dearth of nuclear imaging equipment production. These factors so prevent the industry from growing.
Impact of COVID- 19 pandemic on the nuclear imaging equipment market:
During the COVID-19 pandemic period, all healthcare professionals and patients are affected. COVID-19 influenced the supply chain, product, and service delivery due to the lockdown. The COVID-19 pandemic greatly influenced not just the infected patients but also other people worldwide, particularly in underdeveloped nations and their healthcare systems.
While new studies are often treated in inpatient departments following COVID-19 screening, the majority of nuclear imaging scans and treatments are performed in outpatient departments as follow-up cases. Because portable SPECT and PET scanners are unavailable in nuclear medicine, radiopharmaceuticals must constantly be injected into the patient to allow for unrestricted mobility. Therefore, nuclear medical professionals need to be well-versed in safety precautions to stop COVID-19 transmission. The majority of cardiac patients undergoing nuclear cardiology treatments are often older than 60 and are at extremely high risk for conditions including diabetes, hypertension, chronic renal and lung disorders, and cancer. They are extremely susceptible to acquiring COVID-19 because of all of these circumstances, which has decreased the demand for nuclear imaging treatments. However, many medical professionals think that this drop in treatments is only temporary.
We have various report editions of Nuclear Imaging Equipment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive analysis of the nuclear imaging equipment market:
Some leading players in the nuclear imaging equipment market are, Bracco Imaging SpA, Cardinal Health Inc., Koninklijke Philips NV, Siemens Healthineers, General Electric Company (GE Healthcare), Segami Corporation, Canon Medical Systems Corporation, Positron Corporation, Star Equity Holdings, CMR Naviscan, Inc., SurgicEye GmbH, Mediso Ltd., Rigaku Corporation (MILabs B.V.), MR Solutions Ltd., DDD - Diagnostics A/S, Mirion Technologies (Capintec), Inc., Neusoft Medical Systems Co., Ltd. The market players keep their dominance by spending on research and development, incorporating cutting-edge technology into their products, and releasing advanced products for customers. Market key players use various tactics, including strategic alliances, agreements, mergers, and partnerships.
Recent developments:
June 2023:
Mediso received FDA approval for InterView software
The FDA has approved Mediso's multimodality (PET/SPECT/MRI/CT) image processing and reporting software, known as InterView FUSION and InterView XP, which is specially tailored for nuclear medicine and molecular imaging workflows.
October 2022:
United Imaging Healthcare announced the launch of total-body PET/CT, uEXPLORER
United Imaging Healthcare announced the launch of total-body PET/CT, uEXPLORER, with a 194 cm axial PET field of view (FOV) that allows the complete body to be scanned in a one-bed position. The ultra-high-resolution digital PET/CT system provides total-body dynamic scanning, allowing ultra-low patient dose, and delivering ultra-high picture resolution, thereby revolutionizing whole-body PET/CT imaging.
October 2022
Spectrum Dynamics announced its newest development in digital nuclear medicine imaging
The latest advancement in digital nuclear medicine imaging from Spectrum Dynamics is the capacity to scan high-energy isotopes utilizing solid-state detector technology in a 3600-CZT-based, wide-bore SPECT/CT configuration. The new VERITON-CT 400 Series Digital SPECT/CT scanners have this functionality, enabling imaging applications for the whole body, the brain, the heart, and other organs.
June 2022
Siemens Healthineers Announced FDA Clearance of Symbia Pro.specta SPECT/CT scanner
Siemens Healthineers has announced that the Symbia Pro.spectaTM, a single-photon emission computed tomography/computed tomography (SPECT/CT) system featuring cutting-edge CT and SPECT imaging capabilities, has received FDA clearance. A low-dose CT with up to 64 slices for outstanding detail is one of the capabilities, as are automatic SPECT motion correction and an automated workflow to lead the user through the full examination decision-making process.
April 2022
Mediso Ltd announced the acquisition of Bartec Technologies Ltd
A UK-based firm that specializes in the provision, installation, and maintenance of nuclear medicine and molecular imaging equipment and accessories, Bartec Technologies Ltd., has been acquired by Mediso Ltd. Mediso's market position in the UK and Ireland is strengthened by the purchase.
March 2022
United States Food and Drug Administration (FDA) approved Novartis' complementary diagnostic imaging agent, Locametz
Novartis announced that the US Food and Drug Administration (FDA) approved Pluvicto. For the imaging of adult patients with a specific type of advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that will spread to other parts of the body.
Top Companies Market Share in Nuclear Imaging Equipment Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America held the largest revenue market share over the other regions in the global nuclear imaging equipment market:
North America dominates the nuclear imaging devices market because of the incidence of major market players. Additionally, the increase in the prevalence of cancer and cardiovascular, due to the advancements in technology, including hybrid imaging, the introduction of new radiopharmaceuticals for diagnosis, and the development of molecular imaging.
The United States' booming healthcare industry, rising cancer rates, rising elderly population, and increasing product releases are all contributing to the market's expansion. According to the CDC, there were 602,347 cancer-related deaths and 1,603,844 new cancer cases documented in the United States. In 2020, there were 144 cancer-related deaths and 403 new cancer cases recorded per 100,000 individuals.
Similarly, According to data released by the Canadian government in November 2021, 84,600 Canadians died from cancer in 2021, with an estimated 229,200 receiving a diagnosis. The top cause of mortality in Canada is still cancer. In Canada, an estimated 2 in 5 people will receive a cancer diagnosis throughout their lifetime, and 1 in 4 will pass away from the disease. Nuclear imaging will be more in demand throughout the predicted period as cancer incidence rates grow along with the desire for early diagnosis.
The current report Scope analyzes Nuclear Imaging Equipment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Global Nuclear Imaging Equipment Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Nuclear Imaging Equipment Industry growth. Nuclear Imaging Equipment market has been segmented with the help of its Type, Application End users, and others. Nuclear Imaging Equipment market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By-Products:
By-products, the market is segmented into planar scintigraphy, single photon-emission computed tomography (SPECT) radioisotopes, and PET radioisotopes. where the SPET segment accounted for the largest revenue share in the nuclear imaging equipment market.
The blood flow through the arteries and veins of the brain is observed using a SPECT scan. To identify both benign and malignant cancer types, SPECT has become more widely used in clinical settings. Also. Coronary artery illnesses are diagnosed using non-invasive SPECT imaging technology. The nuclear imaging equipment market in this segment will expand due to the widespread availability, simplicity of use, and low cost of SPECT systems.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nuclear Imaging Equipment Industry. Request a Free Sample PDF!
By application:
By Applications, the market is segmented into cardiology, neurology, thyroid, oncology, and others. The oncology segment held the largest revenue share of the nuclear imaging equipment market.
Due to the rising incidence and prevalence of cancer in the world, the efforts made by both public and private organizations to reduce the risk of cancer, the development of advanced systems, and radiation oncology, the oncology segment holds a sizable portion of the market. This growth is attributed to these factors. FDG (18 fluorine-2-fluoro-2-deoxy-d-glucose) is the radiopharmaceutical used in oncology PET (positron emission tomography), which shows the enhanced metabolism of malignant cells in comparison to normal cells. Lung cancer, lymphoma, head and neck tumors, breast cancer, oesophageal cancer, colorectal cancer, and urinary tract cancers may all be imaged with this method. The market is also expected to rise as a result of increasing nuclear imaging research and development.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Nuclear Imaging Equipment market report 2024 Edition by contacting our team.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Nuclear Imaging Equipment Market is witnessing significant growth in the near future.
In 2023, the Planar Scintigraphy segment accounted for noticeable share of global Nuclear Imaging Equipment Market and is projected to experience significant growth in the near future.
The Oncology segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Siemens Healthineers Germany, GE Healthcare U.S. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Disclaimer:
Type | Planar Scintigraphy, Single Photon-Emission Computed Tomography (SPECT) Radioisotopes, PET Radioisotopes |
Application | Oncology, Cardiology, Neurology, Other |
End users | Hospitals, Imaging centers, academics, and research centers |
List of Competitors | Siemens Healthineers Germany, Philips Healthcare Netherlands, GE Healthcare U.S., Toshiba Medical Systems Corporation Japan, Neusoft Medical Systems China, Mediso Medical Imaging Systems Hungary, Digirad Corporation U.S., CMR Naviscan Corporation U.S., SurgicEye GmbH Germany, DDD Diagnostics Denmark |
This chapter will help you gain GLOBAL Market Analysis of Nuclear Imaging Equipment. Further deep in this chapter, you will be able to review Global Nuclear Imaging Equipment Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America Nuclear Imaging Equipment Market Trends North America Nuclear Imaging Equipment Technological Road Map North America Nuclear Imaging Equipment Market Drivers North America Nuclear Imaging Equipment Market Restraints North America Nuclear Imaging Equipment Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
Chapter 3 Europe Market Analysis
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
Chapter 4 Asia-Pacific Market Analysis
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
Chapter 5 South America Market Analysis
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
Chapter 6 Middle East and Africa Market Analysis
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End users Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Nuclear Imaging Equipment market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Planar Scintigraphy have a significant impact on Nuclear Imaging Equipment market? |
What are the key factors affecting the Planar Scintigraphy and Single Photon-Emission Computed Tomography (SPECT) Radioisotopes of Nuclear Imaging Equipment Market? |
What is the CAGR/Growth Rate of Oncology during the forecast period? |
By type, which segment accounted for largest share of the global Nuclear Imaging Equipment Market? |
Which region is expected to dominate the global Nuclear Imaging Equipment Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Nuclear Imaging Equipment Market
Request Sample